ATS Crit Care

@ATSCritCare · New York, NY cc@thoracic.org · joined 24 Sep 2015

Tweeting for the ATS Critical Care Assembly. @Nick_Ingraham @CatGaoHow @GKamelMD @AliciaNRizzo @Madeehasha @priscillamdlc @ParijatSen11 & others

14 183Followers

129Following

2 404Posts total

3.8KViews on collected posts

Son gönderiler

ATS Crit Care@ATSCritCare4 Aug

Congratulations to Dr. Kelsey Hills-Dunlap on being selected as the CC Assembly's most recent Early Career Professional Highlight! You can read more about her work at https://t.co/EEbUjnktPx 879 views · 8 likes · 0 reposts · 0 replies Open on X →

ATS Crit Care@ATSCritCare26 Jun

Deadline for @ATSCommunity-Endorsed event! Submit Abstract by June 30, 2026 15th @HopkinsMedicine @ICURehab Conference In-Person Conference: Johns Hopkins Hospital Nov 5-6, 2026 https://t.co/qqHCiB7r08 #ICURehab https://t.co/IvB0PsquP0

1.4K views · 6 likes · 5 reposts · 0 replies Open on X →

ATS Crit Care@ATSCritCare20 May

Last we have Dr. Nadir Yehya with "Aging and Analytics: Unlocking Age and Frailty-Based Differences in Treatment Response." @atsearlycareer @ATS_Assemblies @atscommunity #ECPromo2026 #ats2026 #ATSCritCareLive 389 views · 0 likes · 0 reposts · 1 replies Open on X →

ATS Crit Care@ATSCritCare20 May

Dr. Bram Rochwerg on making trials inclusive by design. The SPICE-III data shows dexmedetomidine was likely beneficial in >65 — and likely harmful in ≤65. Same drug. Opposite effects. Age matters. Similar effects in early antibiotics. #ECPromo2026 #ats2026 #ATSCritCareLive https:

662 views · 6 likes · 1 reposts · 1 replies Open on X →

ATS Crit Care@ATSCritCare20 May

Next Dr. Catherine Auriemma talked about metrics in older adults. : For decades, ICU trials chased mortality and 62% of RCTs comparing mortality were underpowered. We built the wrong target. @atsearlycareer @ATS_Assemblies @atscommunity #ECPromo2026 #ats2026 https://t.co/3ysVl6yz

499 views · 1 likes · 1 reposts · 1 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 2 gönderi, 10K–100K takipçi aralığıyla yan yana. geniş kitleye gösteriliyor, ama izleyenlerin azı tepki veriyor.

Medyan görüntülenme1 137bu hesap95010K–100K için medyan

Erişim, %8.02%bu hesap3.31%10K–100K için medyan

Etkileşim, %0.85%bu hesap1.88%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	1 137	950	1.20×
Erişim (görüntülenme ÷ takipçi)	8.02%	3.31%	2.42×
Etkileşim oranı	0.85%	1.88%	0.45×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

49920 May

662

389

1.4K26 Jun

8794 Aug

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.60%20 May

1.21%

0.26%

0.79%26 Jun

0.91%4 Aug

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.88%.

What the audience does

Likes67.7%21 in total

Reposts22.6%7 in total

Replies9.7%3 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Son gönderiler

Aynı büyüklükteki hesaplara karşı

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Benzer hesaplar